Viread ^*

Tenofovir / Viread (generic name: tenofovir disoproxil) is used to treat infections caused by the human immunodeficiency virus type 1 (HIV‑1) and chronic hepatitis B virus (HBV). It belongs to a group of medicines called nucleotide reverse transcriptase inhibitors (NRTIs), which work by blocking a vital enzyme that viruses need to multiply. This action helps slow the spread of infection within the body and allows the immune system to better defend itself.

In the treatment of HIV‑1, Viread helps reduce the amount of virus in the blood. It is typically used as part of a combination therapy, working in conjunction with other antiviral medications. While it does not cure HIV, it can improve immune function, reduce the risk of opportunistic infections, and delay the progression to acquired immunodeficiency syndrome (AIDS). Viread is a core component of many long-term HIV treatment regimens.

For chronic hepatitis B, Tenofovir is used to lower HBV levels in the body and reduce inflammation and damage to the liver. Chronic HBV infection can lead to serious complications such as liver scarring (cirrhosis), liver failure, or liver cancer. Viread helps to suppress viral activity and may improve liver function over time, reducing the risk of these complications.

The drug is often selected because of its high potency against both HIV and HBV and its ability to remain effective against certain drug-resistant strains. It is important for patients using Viread to continue regular monitoring of their condition and to stay under medical supervision, as treatment outcomes depend on consistent management and adherence.

Viread is widely recognized as a well-established treatment and is included in many clinical guidelines worldwide. It plays a key role in public health strategies aimed at controlling the spread of HIV and managing chronic hepatitis B. Its use is generally associated with sustained viral suppression and improved health outcomes in both conditions when managed appropriately.

Dosage

Tenofovir is usually prescribed to be taken once daily, and can be taken with or without food. For adults and adolescents weighing at least 35 kg, the standard dose is 300 mg per day. The tablet should be swallowed whole. For patients who cannot swallow tablets, the medication may be administered as a crushed tablet mixed with a small amount of soft food or liquid.

If a dose is missed and it is within 12 hours of the usual time, the missed dose should be taken as soon as possible. If more than 12 hours have passed, the missed dose should be skipped, and the next dose taken at the regular time. Double dosing should be avoided under all circumstances.

It is important to take Viread consistently to maintain its effectiveness. Missing doses or stopping treatment can lead to a rise in viral levels and increase the risk of resistance or disease progression.

Storage

Viread should be stored at controlled room temperature, ideally between 20-25°C (68-77°F). The tablets should be kept in their original packaging to protect them from moisture and light. Avoid storing the medication in places with excessive heat or humidity, such as bathrooms. Any unused or expired medicines should be disposed of properly, following our guidelines.